SS Innovations International (SSII) Change in Accured Expenses (2016 - 2026)
SS Innovations International's (SSII) quarterly Change in Accured Expenses came in at $256441.0 in Q1 2026, up 430.59% year-on-year from $48331.0 in Q1 2025, and up 21.54% quarter-over-quarter from $210997.0 in Q4 2025.
SS Innovations International (SSII) Change in Accured Expenses (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Change in Accured Expenses across 11 years of filings, most recently posting $256441.0 for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $256441.0, up 430.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $370024.0 (down 24.01% YoY), and the FY2025 annual result was $161914.0, down 85.85% from the prior year.
- Change in Accured Expenses came in at $256441.0 for Q1 2026 at SS Innovations International, up from $210997.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.6 million in Q2 2025 to a low of -$1.7 million in Q3 2025.
- The 5-year median for Change in Accured Expenses is $158047.0 (2023), against an average of $129458.4.
- Across the five-year window, Change in Accured Expenses surged 2126.29% in 2023 and slumped 488.05% in 2025, its largest moves.
- SS Innovations International's Change in Accured Expenses stood at -$249806.0 in 2022, then surged by 192.8% to $231810.0 in 2023, then plunged by 141.96% to -$97261.0 in 2024, then surged by 316.94% to $210997.0 in 2025, then increased by 21.54% to $256441.0 in 2026.
- The last three Change in Accured Expenses figures came in at $256441.0 (Q1 2026), $210997.0 (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | 256,441.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256,441.00 |
| Mar 31, 2026 | 256,441.00 |
| Dec 31, 2025 | 210,997.00 |
| Dec 31, 2025 | 210,997.00 |
| Sep 30, 2025 | -1.68 Mn |
| Sep 30, 2025 | -1.68 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 48,331.00 |
| Mar 31, 2025 | 48,331.00 |
| Dec 31, 2024 | -97,261.00 |
| Dec 31, 2024 | -97,261.00 |
| Sep 30, 2024 | 432,480.00 |
| Sep 30, 2024 | 432,480.00 |
| Jun 30, 2024 | 103,363.00 |
| Jun 30, 2024 | 103,363.00 |
| Mar 31, 2024 | 705,455.00 |
| Mar 31, 2024 | 705,455.00 |
| Dec 31, 2023 | 231,810.00 |
| Dec 31, 2023 | 231,810.00 |